tirzepatide icer NICE recommends Lilly's for type 2 diabetes treatment Tirzepatide (Mounjaro): Type 2 Diabetes

A recent retrospective cohort study found that patients with T2DM on GLP-1RAs experienced fewer asthma exacerbations compared to those on other anti-glycemic agents, having a comparative incidence rate ratio that covers the range of 1.83 to 2.98 [255]

Furthermore, increasing adoption of growth strategies such as launch of Mounjaro in Asian countries is expected to drive the market in the Region

Patient safety is paramount, and no medication should be continued if it poses a significant allergic risk

Not only are vaser lipo results stunning, but the recovery is also shorter as well

This FDA-approved medication, available as both an injectable and an oral pill, mimics the natural GLP-1 hormone to curb appetite and facilitate meaningful, sustained weight loss

Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )